Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents. (Q53155413)
Jump to navigation
Jump to search
scientific article published on 30 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents. |
scientific article published on 30 May 2011 |
Statements
Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents. (English)
1 reference
1 reference
1 reference
Eurydiki Michalis
1 reference
Maria Gkotzamanidou
1 reference
Evangelos Terpos
1 reference
Ekaterini Stefanoudaki
1 reference
Dimitrios Christoulas
1 reference
Konstantinos Anargyrou
1 reference
Eirini Katodritou
1 reference
Anastasia Pouli
1 reference
Konstantinos Tsionos
1 reference
Sosana Delimpasi
1 reference
John Meletis
1 reference
Athanasios Papatheodorou
1 reference
Nikitas Nikitas
1 reference
Vasilios Koumoustiotis
1 reference
Dimitrios Margaritis
1 reference
Konstantinos Zervas
1 reference
Greek Myeloma Study Group, Greece
1 reference
30 May 2011
1 reference
130
1 reference
3
1 reference
735-742
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference